News and Announcements
Proteomics to Expand Operations in Indian Market
- Published April 15, 2016 10:40AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th April 2016, ASX Announcement
Highlights:
- PILL to expand to Indian biotech sector – rapidly growing global biotech hub forecast to be worth $US100b by 2025.
- PILL to conduct India trade visit this month to drive uptake to biosimilars analytics and biomarker services.
- Company appoints Regional Sales Manager for India as part of its Indian growth strategy.
Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce the expansion of its operations in the massive Indian biotechnology industry.
India represents a significant, global biotechnology jurisdiction, forecast to grow at an average rate of 30% per year to be worth US$100 billion by 2015. PILL has operated successfully in India since 2004, and will now expand its operations to take advantage burgeoning opportunities for its proteomics-based services.
To view the full article please click on the button below.